chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Skin tightness, Tension
Clinical narrative: Felt a lump in my left armpit; I had gotten shortness of breath feeling; I had gotten feeling tired; I had gotten feeling weak; I felt hot; Sides felt like it had getting tight; I felt dizzy; My body had tensing up; Feel my body or hardly breath.; Through out the day I was getting worse; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: ER8736) via an unspecified route of administration in the left arm on 24May2021 at 16:00 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. The relevant medical history was not reported. The patient had no allergies to medications, food or other products. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 25May2021 the patient experienced felt a lump in left armpit, worse, shortness of breath, feeling tired, feeling weak, felt hot, sides felt like it had getting tight, felt dizzy, body had tensing up and feel body or hardly breath. It's reported that the patient had a lump in left armpit throughout the day had worse, shortness of breath feeling tired, and weak. He felt hot so drinking Gatorade then a couple of minutes later sides felt like it had to get tight and felt dizzy then when an inside body had to tense up and he couldn't feel the body or hardly breath. No therapeutic measures were taken as a result of reported events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events of felt a lump in left armpit, worse, shortness of breath, feeling tired, feeling weak, felt hot, sides felt like it had getting tight, felt dizzy, body had tensing up and feel body or hardly breath was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hyperhidrosis, Myalgia, Rash
Clinical narrative: Rash on abdomen and back; Sweating; severe muscle ache; severe joint ache; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0187) via an unspecified route of administration in the left arm on 25May2021 at 08:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient previously received amoxicillin, clavulanic acid (AUGMENTIN) on an unspecified date for an unspecified indication and experienced drug allergy. The patient did not take any other medications within two weeks. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 08:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25May2021 (12-36 hours after vaccination), the patient experienced sweating, severe muscle and joint aches. On 26May2021, the patient experienced rash on abdomen and back. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events sweating, severe muscle and joint aches and rash on abdomen and back was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Muscle spasms, Myalgia, Pain
Clinical narrative: Muscle cramping; Pain; Muscle aches; Severe joint aches; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736), via an unspecified route of administration in the left arm on 23Apr2021 at 14:45 (at the age of 47-year-old), as a single dose for COVID-19 immunisation. Medical history included heart attack from July 2020, spinal disorder, back/spinal issues and arthritis. The patient did not have a history of allergies to any food or medications or other products. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), ticagrelor (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN) and acetylsalicylic acid (LOW DOSE ASA) for an unknown indication from an unknown dates. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533), via an unspecified route of administration in the left arm on 02Apr2021 at 10:45 (at the age of 47-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Apr2021 at 18:00, the patient experienced muscle aches, severe joint aches, and muscle cramping which continued at the time of report. The patient has been unable to continue lifting weights and doing cardio regularly as the patient had prior because of the pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the events. The clinical outcome of the events muscle aches, severe joint aches, muscle cramping and pain were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: injection site pain; headache; chills; tiredness; sensitive skin/hair follicles; muscle pain; joint pain; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26May2021 at 15:15 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Patient had no relevant medical history. Patient had no known allergies reported. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 16:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27May2021 at 08:00, the patient experienced injection site pain, headache, chills, tiredness, sensitive skin/hair follicles, muscle and joint pain. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain, headache, chills, tiredness, sensitive skin/hair follicles, muscle and joint pain was unknown at the time of this report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Sensitive skin, Vaccination site pain
Clinical narrative: injection site pain; headache; chills; tiredness; sensitive skin/hair follicles; muscle pain; joint pain; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26May2021 at 15:15 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Patient had no relevant medical history. Patient had no known allergies reported. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 16:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27May2021 at 08:00, the patient experienced injection site pain, headache, chills, tiredness, sensitive skin/hair follicles, muscle and joint pain. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain, headache, chills, tiredness, sensitive skin/hair follicles, muscle and joint pain was unknown at the time of this report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Inappropriate schedule of product administration
Clinical narrative: Shingles diagnosis; Dose 1: 21Apr2021, Dose 2: 03May2021; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 03May2021 at 09:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to almonds. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included mometasone spray (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC) and olopatadine spray (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 21Apr2021 at 09:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27May2021 at 09:15, the patient experienced shingles diagnosis. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with Valtrex. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event shingles diagnosis was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea
Clinical narrative: Chest pain; Labored breathing; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWA73) via an unspecified route of administration in the right arm on 19May2021 at 15:30 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. Concomitant medications included ethinylestradiol, norethisterone acetate (MICROGESTIN) for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Era735) via an unspecified route of administration in the right arm on 28Apr2021 at 14:00  (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23May2021 at 14:00 the patient experienced chest pain and labored breathing. No therapeutic measures were taken as a result of the events. The events resulted in emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event chest pain and labored breathing was recovering at the time of report.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Memory impairment, Paraesthesia oral
Clinical narrative: Tongue numb and tingling, after first vaccine; Feels like days are blurred together, after first vaccine; Tongue numb and tingling, after first vaccine; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration on an unspecified date as single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. She stated she had an odd side effect, and she feels like all of her days have blurred together. She stated that everyday since she got her first vaccine, throughout the day, her tongue goes numb and it tingles. She stated that she was able to taste. She has not called previously, because she thought this was a weird effect. She stated the effect was not that annoying to her now, but she was unsure if the second dose will make it worse. She stated that today, she was supposed to go get her second vaccine. Reclarified, she was not sure if she should get her vaccine today, or not. She wanted to report her event first, in case Pfizer recommended that she see her doctor before getting the second vaccine. She has her vaccine appointment in the next half hour at a walk in clinic. She has contacted her doctor and left them a message but they have not called her back. She stated that her husband was at the doctor yesterday, and he asked the doctor about her effects. The doctor stated that those effects are some that have been reported. She asks the DSU agent if she should hold off on the second dose? She stated she can speak to a provider in the clinic where she got her first vaccine, about her effect, if she can't reach her doctor. The outcome of events was unknown.  Information on the Lot/Batch number has been requested.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Dissociative disorder, Ear discomfort, Hypoacusis
Clinical narrative: Partial hearing loss, ears are very cloudy feeling.; Partial hearing loss, ears are very cloudy feeling.; I also experience dissociation regularly but the vaccine seems to have made it more common.; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 26May2021 at 12:45 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, anorexia nervosa and dissociation reaction. Concomitant medications taken within two weeks of vaccination included lithium (MANUFACTURER UNKNOWN), cyanocobalamin (VITAMIN B12), echinacea spp. (ECHINACEA), calcium (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN) and biotin (MANUFACTURER UNKNOWN), all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27May2021 at 08:00, the patient experienced partial hearing loss, ears had very cloudy feeling. The patient also experienced dissociation regularly but the vaccine seemed to have made it more common. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events partial hearing loss, ears had very cloudy feeling, also experience dissociation regularly but the vaccine seemed to have made it more common was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Diarrhoea, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Lymphadenopathy all areas of left side of body; Diarrhea; Fever 102f; Body ache; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0168), via an unspecified route of administration in left arm on 26May2021 at 16:45 (at the age of 34-year-old) at single dose for COVID-19 immunisation. Medical history included diagnosed with COVID-19 prior to the vaccination. Concomitant medications included midodrine and omeprazole. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0167) via an unspecified route of administration in left arm on 05May2021 at 16:45 (at the age of 34-year-old) at single dose for COVID-19 immunisation. On 27May2021, the patient experienced lymphadenopathy all areas of left side of body, diarrhea, fever 102f (Fahrenheit) and body ache. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pain
Clinical narrative: a fever of 100 degrees; chills; headache; tired; my body felt sore; My arm was sore the evening of the day I received the shot/I woke up the next day with my arm more sore; This is a spontaneous report from a contactable consumer or other non HCP (Patient) and a Pharmacist. A 66-year-old female patient received bnt162b2 (BNT162B2, formulation; Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 25May2021 15:00 (Batch/Lot number was not reported) as DOSE 1, SINGLE (at the age of 66-year-old) for covid-19 immunisation. Medical history included COVID-19 (Prior to vaccination the patient diagnosed with COVID-19) from an unknown date and unknown if ongoing, The patient had no known allergies. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR) and estradiol (ESTRING) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient stated that "My arm was sore the evening of the day I received the shot, I woke up the next day at 07:00 AM with my arm more sore. I had a fever of 100 degrees along with chills and a headache. I was tired and my body felt sore" . Since the vaccination, the patient had not been tested for COVID-19. No treatment was received for the events. The outcome of the events reported as recovered on an unknown date of May2021.  The batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: a fever of 100 degrees; chills; headache; tired; my body felt sore; My arm was sore the evening of the day I received the shot/I woke up the next day with my arm more sore; This is a spontaneous report from a contactable consumer or other non HCP (Patient) and a Pharmacist. A 66-year-old female patient received bnt162b2 (BNT162B2, formulation; Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 25May2021 15:00 (Batch/Lot number was not reported) as DOSE 1, SINGLE (at the age of 66-year-old) for covid-19 immunisation. Medical history included COVID-19 (Prior to vaccination the patient diagnosed with COVID-19) from an unknown date and unknown if ongoing, The patient had no known allergies. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR) and estradiol (ESTRING) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient stated that "My arm was sore the evening of the day I received the shot, I woke up the next day at 07:00 AM with my arm more sore. I had a fever of 100 degrees along with chills and a headache. I was tired and my body felt sore" . Since the vaccination, the patient had not been tested for COVID-19. No treatment was received for the events. The outcome of the events reported as recovered on an unknown date of May2021.  The batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Maternal exposure during pregnancy, gestation period 24 weeks; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24May2021 at 10:45 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease, allergic to latex, bee venom, gluten and shellfish. The patient's last menstrual date was on 11Dec2020 and delivery date was reported as 17Sep2021. Concomitant medications were not reported.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24May2021, the patient experienced maternal exposure during pregnancy, gestation period 24 weeks. The clinical outcome of the event maternal exposure during pregnancy was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Dizziness, Fatigue, Feeling abnormal, Neck pain
Clinical narrative: Under arm pain; Dizziness; Brain fog; Neck pain; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 25May2021 at 11:00 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Medical history included anemia, since unknown date. The patient did not have any allergies to food, medications, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on an unknown date, as a single dose for COVID-19 immunisation. On 26May2021 at 12:00, the patient experienced under arm pain, dizziness, brain fog, neck pain and fatigue. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events under arm pain, dizziness, brain fog, neck pain and fatigue were not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Fatigue, Movement disorder, Pain in extremity, Somnolence
Clinical narrative: Soreness in arm - difficulty moving and sore to touch; Prone to napping; minor dehydration; Constantly thirsty; Soreness in arm - difficulty moving and sore to touch; Fatigue - tired; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0202) in the left arm on 27May2021 at 15:30 (at the age of 27-years-old) as a dose for COVID-19 immunisation. Medical history included anemia and allergic to beef. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28May2021 at 00:30, the patient experienced soreness in arm, difficulty moving and sore to touch, fatigue tired, prone to napping, minor dehydration and was constantly thirsty but nothing extreme. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events soreness in arm, difficulty moving and sore to touch, fatigue tired, prone to napping, minor dehydration and constantly thirsty were unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Thirst
Clinical narrative: Soreness in arm - difficulty moving and sore to touch; Prone to napping; minor dehydration; Constantly thirsty; Soreness in arm - difficulty moving and sore to touch; Fatigue - tired; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0202) in the left arm on 27May2021 at 15:30 (at the age of 27-years-old) as a dose for COVID-19 immunisation. Medical history included anemia and allergic to beef. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28May2021 at 00:30, the patient experienced soreness in arm, difficulty moving and sore to touch, fatigue tired, prone to napping, minor dehydration and was constantly thirsty but nothing extreme. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events soreness in arm, difficulty moving and sore to touch, fatigue tired, prone to napping, minor dehydration and constantly thirsty were unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Pain, Pyrexia, Vomiting
Clinical narrative: Fever; throwing up; Feel very weak and sore; Feel very weak and sore; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25May2021 at 17:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included lung scarring, irregular heartbeat and heart murmur. Concomitant medications included levetiracetam (KEPPRA) from unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in May2021 the patient had a fever for two days and was still on going and he had throwing up, and just feel very weak and sore. This was only the first dose and the patient worried about the second dose. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event fever was not recovered and of the event throwing up, just feel very weak and sore was unknown.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen lymph nodes in armpit that were painful; Swollen lymph nodes in armpit that were painful; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22May2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23May2021 at 07:45, the patient experienced swollen lymph nodes in armpit that were painful. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event swollen lymph nodes in armpit that were painful was unknown at the time of this report.   The batch/lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Neck pain
Clinical narrative: Severe neck pain; Stiff neck on right side.; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26May2021 (at the age of 42-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The information on known allergies to medications, food or other products was not applicable. The clinical course was reported as follows: on 26May2021, the patient experienced severe neck pain and stiff neck on right side. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of severe neck pain and stiff neck on right side was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Blood test, Computerised tomogram, Immature granulocyte count, SARS-CoV-2 test
Clinical narrative: upper right quadrant pain; prominent immature granulocytes; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 23Apr2021 at 17:45 as a single dose for COVID-19 immunisation. Medical history included fibromyalgia and penicillin allergy. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 26Apr2021 the patient experienced upper right quadrant pain. The patient had to go to the ER because of a upper right quadrant pain. Some studies were conducted which included (Blood, XRAY, CT Scan) and told that the patient had prominent immature granulocytes and some markings on my lungs which the patient had never before. The patient needed to know if this can be a consequence of the vaccine as it was the only thing different that she had done and  had never been mentioned any of this condition before this vaccine. The event resulted in emergency room/department or urgent care.  On 26Apr2021, the patient underwent blood test, CT scan and XRAY and the results were prominent immature granulocytes and some markings on her lungs which the patient never had before. On 11May2021, the patient underwent nasal swab and the result was negative. Therapeutic measures were unknown whether taken as a result of the event. The clinical outcome of the events upper right quadrant pain was not recovered at the time of this report.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: upper right quadrant pain; prominent immature granulocytes; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 23Apr2021 at 17:45 as a single dose for COVID-19 immunisation. Medical history included fibromyalgia and penicillin allergy. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 26Apr2021 the patient experienced upper right quadrant pain. The patient had to go to the ER because of a upper right quadrant pain. Some studies were conducted which included (Blood, XRAY, CT Scan) and told that the patient had prominent immature granulocytes and some markings on my lungs which the patient had never before. The patient needed to know if this can be a consequence of the vaccine as it was the only thing different that she had done and  had never been mentioned any of this condition before this vaccine. The event resulted in emergency room/department or urgent care.  On 26Apr2021, the patient underwent blood test, CT scan and XRAY and the results were prominent immature granulocytes and some markings on her lungs which the patient never had before. On 11May2021, the patient underwent nasal swab and the result was negative. Therapeutic measures were unknown whether taken as a result of the event. The clinical outcome of the events upper right quadrant pain was not recovered at the time of this report.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Myalgia, Pyrexia, Sensitive skin
Clinical narrative: Vomiting for 24 hours; Severe muscle aches; fever; no energy; sensitive skin; Tired; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 29Mar2021 at 15:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included progesterone (MANUFACTURER UNKNOWN) as contraceptive pill from an unknown date and unknown if ongoing. On 20Apr2021 at 03:00, the patient had experienced vomiting for 24 hours, severe muscle aches, fever, no energy, sensitive skin and tired. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the adverse events.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vomiting, severe muscle aches, fever, no energy, sensitive skin and tired was recovered on an unknown date in 2021.  The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Vomiting for 24 hours; Severe muscle aches; fever; no energy; sensitive skin; Tired; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 29Mar2021 at 15:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included progesterone (MANUFACTURER UNKNOWN) as contraceptive pill from an unknown date and unknown if ongoing. On 20Apr2021 at 03:00, the patient had experienced vomiting for 24 hours, severe muscle aches, fever, no energy, sensitive skin and tired. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the adverse events.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vomiting, severe muscle aches, fever, no energy, sensitive skin and tired was recovered on an unknown date in 2021.  The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Headache, Nausea, Pain in extremity
Clinical narrative: injection site pain; arm soreness; headaches; dizziness; nausea; diarrheas; swelling; vomits; This is a spontaneous report from a non-contactable consumer, the patient. A patient of unknown age and  unknown gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the left arm on 25May2021, as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 04May2021, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The clinical course was reported as follows: on an unknown date in May2021, the patient experienced injection site pain, arm soreness, headaches, dizziness, nausea, diarrheas, swelling and vomits. The clinical outcome of the event injection site pain, arm soreness, headaches, dizziness, nausea, diarrheas, swelling and vomits was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected
Sex: U
Vaccine: COVID19
Symptoms: Swelling, Vaccination site pain, Vomiting
Clinical narrative: injection site pain; arm soreness; headaches; dizziness; nausea; diarrheas; swelling; vomits; This is a spontaneous report from a non-contactable consumer, the patient. A patient of unknown age and  unknown gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the left arm on 25May2021, as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 04May2021, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The clinical course was reported as follows: on an unknown date in May2021, the patient experienced injection site pain, arm soreness, headaches, dizziness, nausea, diarrheas, swelling and vomits. The clinical outcome of the event injection site pain, arm soreness, headaches, dizziness, nausea, diarrheas, swelling and vomits was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: No menstruation in the months of Apr or May so far; This is a spontaneous report from a contactable consumer. This 47-year-old non-pregnant female consumer (patient) reported for herself that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: DCHD/cu EW 0170) via an unspecified route of administration on an unspecified date on left arm (at 47-year-old), as dose 2, single for COVID-19 immunization. Medical history of included asthma, wheezing, pulmonary function test decreased, dyspnoea, drug hypersensitivity (start date and ongoing status unknown). Concomitant medications included fluticasone propionate, salmeterol xinafoate (Advair) taken for an unspecified indication, start and stop date were not reported; cetirizine hydrochloride (Zyrtec [Cetirizine Hydrochloride]) taken for an unspecified indication, start and stop date were not reported; levothyroxine taken for an unspecified indication, start and stop date were not reported; spironolactone taken for an unspecified indication, start and stop date were not reported. It was mentioned that patient was diagnosed with COVID-19 prior to vaccination. She has not been tested for COVID-19 since the vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: Eng 204 DCHD/cu,) via an unspecified route of administration on 02Apr2021 at 01:00 PM on left arm (at 47-year-old), as dose 1, single for COVID-19 immunization. It was mentioned that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 12Apr2021 the patient had no menstruation in the months of Apr or May so far, and problem might continue. No treatment was received. The patient had not recovered. The device date was 29May2021.  Follow-up (01Jul2021): Follow-up attempts completed. No further information was expected.  Follow-Up (23Jul2021): Follow-up attempts are completed. No further information was expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hypoaesthesia, Influenza like illness, Muscle twitching, Muscular weakness
Clinical narrative: Numbness; weak muscles; muscle twitching; Chills; flu-like symptoms without fever; This is a spontaneous report received from a contactable consumer (Patient). A 45-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) via an unspecified route of administration at left arm on 28Apr2021 12:00 (at the age of 45-year-old) (Lot Number: EP7534) as single dose for COVID-19 immunisation. Medical history included guillain-barre syndrome (previously had), factor V leiden and HIV and concomitant medications included bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate (BIKTARVY) and apixaban (ELIQUIS). The patient did not receive other vaccine in four weeks. The patient did not test COVID post vaccination. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) via an unspecified route of administration at left arm on 07Apr2021 12:00 (at the age of 45-year-old) (Lot Number: EN6199) as single dose for COVID-19 immunisation. The patient had neurological symptoms 6 weeks after vaccination. Numbness, weak muscles, muscle twitching, chills and flu-like symptoms without fever on 01May2021. Lasting 4 weeks now. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 21May2021. Patient visits the physician office and emergency room for the events and no treatment received for the events. Outcome of events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Oligomenorrhoea, Platelet count decreased, SARS-CoV-2 antibody test, Vertigo
Clinical narrative: vertigo very bad and continues; Menstrual period lasting longer; low blood platelet count; This is a spontaneous report from a contactable reporter via COVAES. A 40-year-old (non-pregnant) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 05May2021 10:00 as (At the age of 40-year) dose 2, single for covid-19 immunisation. Medical history included migraine, autoimmune arthritis, (I believe autoimmune deficiency arthritis of some aurtis) and covid-19 from an unknown date. The patient concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was Unknown if patient been tested for COVID-19 Since the vaccination. Patient was not pregnant at the time of vaccination. The patient previously took bnt162b2, dose 1, administered in Right arm on 05Apr2021 10:00 as dose 1, single for covid-19 immunisation. It was reported that adverse event Began after the 2nd shot vertigo very bad and continues. Menstrual period lasting longer. Testing shows low blood platelet count on May2021. Patient was visited Doctor or other healthcare professional office/clinic for events ae treatment Vertigo Meds- Lab work showing low blood platelets retested 28May2021 and awaiting results. The patient underwent lab tests and procedures which included platelet count decreased: unknown on 28May2021, platelet count decreased: low blood platelets in 2021, sars-cov-2 antibody test: positive on unknown date. The outcome of events was not recovered.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.